[go: up one dir, main page]

DE69617654D1 - Nitroglycerin enthaltende topische creme auf wasserbasis, verfahren zu deren herstellung und verwendung - Google Patents

Nitroglycerin enthaltende topische creme auf wasserbasis, verfahren zu deren herstellung und verwendung

Info

Publication number
DE69617654D1
DE69617654D1 DE69617654T DE69617654T DE69617654D1 DE 69617654 D1 DE69617654 D1 DE 69617654D1 DE 69617654 T DE69617654 T DE 69617654T DE 69617654 T DE69617654 T DE 69617654T DE 69617654 D1 DE69617654 D1 DE 69617654D1
Authority
DE
Germany
Prior art keywords
production
water
cream containing
topical cream
based topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69617654T
Other languages
English (en)
Other versions
DE69617654T2 (de
Inventor
Michael P Allen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Medical Innovations Inc
Original Assignee
International Medical Innovations Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Medical Innovations Inc filed Critical International Medical Innovations Inc
Application granted granted Critical
Publication of DE69617654D1 publication Critical patent/DE69617654D1/de
Publication of DE69617654T2 publication Critical patent/DE69617654T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69617654T 1995-03-06 1996-03-05 Nitroglycerin enthaltende topische creme auf wasserbasis, verfahren zu deren herstellung und verwendung Expired - Lifetime DE69617654T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39887295A 1995-03-06 1995-03-06
US08/594,304 US5698589A (en) 1993-06-01 1996-01-30 Water-based topical cream containing nitroglycerin and method of preparation and use thereof
PCT/US1996/002989 WO1996027372A1 (en) 1995-03-06 1996-03-05 Water-based topical cream containing nitroglycerin; method of preparation and use thereof

Publications (2)

Publication Number Publication Date
DE69617654D1 true DE69617654D1 (de) 2002-01-17
DE69617654T2 DE69617654T2 (de) 2002-08-08

Family

ID=27016409

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69617654T Expired - Lifetime DE69617654T2 (de) 1995-03-06 1996-03-05 Nitroglycerin enthaltende topische creme auf wasserbasis, verfahren zu deren herstellung und verwendung

Country Status (21)

Country Link
US (1) US5698589A (de)
EP (1) EP0814800B1 (de)
JP (1) JPH11501629A (de)
KR (1) KR19980702766A (de)
CN (1) CN1139380C (de)
AP (1) AP691A (de)
AT (1) ATE209895T1 (de)
AU (1) AU701328B2 (de)
BR (1) BR9607974A (de)
CZ (1) CZ281897A3 (de)
DE (1) DE69617654T2 (de)
EA (1) EA000566B1 (de)
HU (1) HUP9801234A3 (de)
NO (1) NO974075L (de)
NZ (1) NZ305095A (de)
OA (1) OA10504A (de)
PL (1) PL322110A1 (de)
SI (1) SI9620038A (de)
SK (1) SK117597A3 (de)
TR (1) TR199700909T1 (de)
WO (1) WO1996027372A1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
GB2325855B (en) * 1997-06-04 2001-08-29 Healthscene Ltd Preparation for topical application to the male sexual organ
EP1535611A3 (de) * 1997-06-23 2009-09-16 Strakan International Limited Microdosistherapie von Gefässbedingten Erscheinungen durch NO-Donoren
ES2257813T3 (es) * 1997-06-23 2006-08-01 Cellegy Pharmaceuticals, Inc Terapia de microdosis de condiciones vasculares mediante donadores de no.
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US6593369B2 (en) 1997-10-20 2003-07-15 Vivus, Inc. Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US20050070516A1 (en) * 1997-10-28 2005-03-31 Vivus Inc. As-needed administration of an androgenic agent to enhance female desire and responsiveness
EP1027057A4 (de) 1997-10-28 2003-01-02 Vivus Inc Behandlung von weibliche sexuelle störungen
US20040014761A1 (en) * 1997-10-28 2004-01-22 Place Virgil A. Treatment of female sexual dysfunction with phosphodiesterase inhibitors
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
GB9802078D0 (en) * 1998-01-30 1998-03-25 Futura Medical Limited Preparation for treatment of erectile dysfunction
WO1999062533A1 (en) * 1998-06-04 1999-12-09 Jedco Products, Llc Preparation for topical application to the male sexual organ
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction
GB9818524D0 (en) * 1998-08-25 1998-10-21 Futura Medical Limited Inorgasmia treatment
IT1303793B1 (it) * 1998-11-27 2001-02-23 Promefarm S R L "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)"
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
DE60131644T2 (de) 2000-05-09 2008-10-30 Nitromed, Inc., Lexington Infrarotthermographie und behandlung von sexuellen dysfunktionen
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
EP1328281B1 (de) * 2000-06-27 2007-08-15 Qualilife Pharmaceuticals Inc. Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
HUP0002628A2 (en) * 2000-07-14 2002-06-29 Keri Pharma Kft Pharmaceutical combinations for treating diabetes
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DK1315502T3 (da) * 2000-08-30 2010-07-19 Unimed Pharmaceuticals Llc Fremgangsmåde til behandling af erektil dysfunktion og til forøgelse af mænds libido
JP2005504721A (ja) * 2001-03-06 2005-02-17 セレジィ ファーマシューティカルス， インコーポレイテッド 尿生殖障害の処置のための化合物および方法
JP2003040763A (ja) * 2001-05-23 2003-02-13 Taisho Pharmaceut Co Ltd 多価アルコール含有軟膏剤基剤
SE0103528D0 (sv) * 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
IL162154A0 (en) * 2002-02-15 2005-11-20 Nexmed Holdings Inc Prostagandin composition for the treatment of erectile dysfunction
UA80964C2 (en) * 2002-03-15 2007-11-26 Unimed Pharmaceuticals Inc Method for treating depression and kit therefor
WO2004091631A1 (en) * 2002-03-15 2004-10-28 Unimed Pharmaceuticals, Inc. Androgen pharmaceutical composition and method for treating depression
EP2017617A1 (de) 2002-12-23 2009-01-21 William Marsh Rice Univeristy Wundverband
US7763256B2 (en) * 2002-12-23 2010-07-27 William Marsh Rice University Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
US20100297074A1 (en) * 2002-12-23 2010-11-25 Richard Hans Gomer Wound healing compositions, systems, and methods
US8012472B2 (en) * 2002-12-23 2011-09-06 William Marsh Rice University Compositions and methods for suppressing fibrocytes
US20050031699A1 (en) 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
GB0417675D0 (en) 2004-08-09 2004-09-08 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
AU2005307736A1 (en) * 2004-11-17 2006-05-26 Lindsey Berkson Composition and method for facilitating the healing of non-healing and slow-healing wounds and ulcerations
US20060127483A1 (en) * 2004-12-10 2006-06-15 Alan Drizen Topical drug delivery system
GB0602224D0 (en) * 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
EP2094289B1 (de) * 2006-12-04 2013-03-13 Promedior, Inc. Kombination von sap und enalapril zur verwendung in der behandlung von fibrotischen und fibroproliferativen erkrankungen
US8497243B2 (en) * 2007-07-06 2013-07-30 Promedior, Inc. Methods and compositions useful in the treatment of mucositis
US9884899B2 (en) 2007-07-06 2018-02-06 Promedior, Inc. Methods for treating fibrosis using CRP antagonists
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
DE202008007318U1 (de) * 2008-03-14 2008-07-31 G. Pohl-Boskamp Gmbh & Co. Kg Langzeitstabile pharmazeutische Zubereitung mit dem Wirkstoff Glyceroltrinitrat
US20100263675A1 (en) * 2009-04-21 2010-10-21 Ansell Healthcare Products Llc Condom with Localized Active Agent
US20100035929A1 (en) * 2008-06-09 2010-02-11 Lindsley Craig W Unnatural dispyrin analogues, preparation and uses thereof
US20100016446A1 (en) * 2008-07-21 2010-01-21 Sylvia Gonda Stable water-based topical pharmaceutical creams and methods of making and using same
WO2010057117A2 (en) * 2008-11-14 2010-05-20 Helm Pharmaceuticals, Inc. Topical transdermal drug delivery compositions
JP5797565B2 (ja) * 2009-03-11 2015-10-21 プロメディオール， インコーポレイテッド 過敏性障害（ｈｙｐｅｒｓｅｎｓｉｔｉｖｅ ｄｉｓｏｒｄｅｒ）に対する処置および診断方法
US10702583B2 (en) * 2009-03-11 2020-07-07 Promedior, Inc. Treatment methods for autoimmune disorders
UA110323C2 (en) * 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
HUE041034T2 (hu) * 2009-06-17 2019-05-28 Promedior Inc SAP-variánsok és alkalmazásuk
WO2011057386A1 (en) * 2009-11-13 2011-05-19 Oral Delivery Technology Ltd. Composition and prophylactic device for enhancing sexual performance or pleasure
WO2012016690A1 (en) 2010-08-03 2012-02-09 G. Pohl-Boskamp Gmbh & Co. Kg Use of glyceryl trinitrate for treating hematomas
ES2672261T3 (es) 2011-02-25 2018-06-13 G. Pohl-Boskamp Gmbh & Co. Kg Gránulos estabilizados que contienen trinitrato de glicerilo
US9248099B2 (en) 2012-05-31 2016-02-02 Desmoid Aktiengesellschaft Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
ES2617494T3 (es) 2012-05-31 2017-06-19 G. Pohl-Boskamp Gmbh & Co. Kg Inducción de arteriogénesis con un donador de óxido nítrico tal como nitroglicerina
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
EP2878310B1 (de) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprühbare wässrige Zusammensetzung mit Nitroglycerin
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーＯｎｑｕａｌｉｔｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｈｉｎａ Ｌｔｄ． Ｅｇｆｒ阻害に関連する疾患を予防又は治療する方法
JP7520366B2 (ja) 2018-04-16 2024-07-23 オンクオリティー ファーマシューティカルズ チャイナ リミテッド 腫瘍療法の副作用の予防または治療方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4336243A (en) * 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5001151A (en) * 1987-08-11 1991-03-19 Fujisawa Usa, Inc. Aqueous nitroglycerin injection and manufacturing process
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof

Also Published As

Publication number Publication date
CN1177294A (zh) 1998-03-25
US5698589A (en) 1997-12-16
EA000566B1 (ru) 1999-12-29
CN1139380C (zh) 2004-02-25
PL322110A1 (en) 1998-01-05
TR199700909T1 (xx) 1998-02-21
WO1996027372A1 (en) 1996-09-12
AU5302596A (en) 1996-09-23
DE69617654T2 (de) 2002-08-08
NO974075D0 (no) 1997-09-04
AU701328B2 (en) 1999-01-28
JPH11501629A (ja) 1999-02-09
HUP9801234A2 (hu) 1999-01-28
ATE209895T1 (de) 2001-12-15
NZ305095A (en) 2005-05-27
SI9620038A (sl) 1998-04-30
EP0814800A1 (de) 1998-01-07
EP0814800B1 (de) 2001-12-05
NO974075L (no) 1997-10-27
HK1005359A1 (en) 1999-01-08
SK117597A3 (en) 1998-01-14
HUP9801234A3 (en) 2000-07-28
AP691A (en) 1998-10-12
CZ281897A3 (en) 1997-12-17
AP9701068A0 (en) 1997-10-31
EA199700213A1 (ru) 1998-02-26
KR19980702766A (ko) 1998-08-05
OA10504A (en) 2002-04-24
BR9607974A (pt) 1998-01-13
EP0814800A4 (de) 1998-07-01

Similar Documents

Publication Publication Date Title
DE69617654D1 (de) Nitroglycerin enthaltende topische creme auf wasserbasis, verfahren zu deren herstellung und verwendung
DE59806467D1 (de) Benzamidoxim-derivate, zwischenprodukte und verfahren zu deren herstellung und deren verwendung als fungizide
ATE202553T1 (de) Phenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und sie enthaltende mittel
DE59307218D1 (de) Modifizierte polyasparaginsäuren, verfahren zu ihrer herstellung und ihre verwendung
DE69633554D1 (de) Festdielektrikumkondensator und verfahren zu seiner herstellung
DE69710484D1 (de) Übergezogene süsswaren und verfahren zu deren herstellung
DE69608359D1 (de) Hexaazaisowurtzitan-derivate und verfahren zu deren herstellung
ATE232879T1 (de) Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE69625176D1 (de) Camptothecin-derivate und verfahren zu ihrer herstellung
ATE40826T1 (de) 4'-demethyl-4-epipodophyllotoxinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69332117D1 (de) 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung
ATE263144T1 (de) Neue phenylamidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE59600453D1 (de) Zinnbadbodenstein, und Verfahren zu seiner Herstellung
DE59505795D1 (de) Iminooxymethylenanilide, verfahren und zwischenprodukte zu ihrer herstellung und sie enthaltende schädlingsbekämfungsmittel
DE69634530D1 (de) Antivirales mittel und verfahren zu dessen herstellung
ATE301645T1 (de) Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69318181D1 (de) Papierblock, streifen und verfahren zu deren herstellung
DE69523571D1 (de) Pyridylimidazol-derivate und verfahren zu ihrer herstellung
DE69630873D1 (de) Propylen-1-penten copolymerisate, verfahren zu deren herstellung und zusammensetzungen diese enthaltend
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.
DE69527445D1 (de) Aminooligosaccharid-derivate und verfahren zu ihrer herstellung
DE69518647D1 (de) Pyridyl-imidazol-derivate und verfahren zu ihrer herstellung
AT399880B (de) Neue thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE59608892D1 (de) Iminooxyphenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung
ATE217008T1 (de) Erythromycinderivate, verfahren zu ihrer herstellung, und ihrer verwendung als arzneimitteln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition